Stenabolic SR9009 - 60 Tablets

In stock

Lab tested · Dec 2025
£54.95

Stenabolic (SR9009) supplied as 60 tablets, each with 10mg. SR9009 is a synthetic agonist of the REV-ERB nuclear receptors, which form part of the circadian clock, and was first reported by Scripps Research scientists in 2012. It is not a SARM. For laboratory research.

Supplied for Research Purposes Only This information and product is provided for research purposes only. We do not provide any advice on the usage of these products. These products are for sale to persons aged 18 and over only. Customers should check the legality of this product in their own country prior to purchase.

Certificate of analysis

Independently tested by MZ Biolabs

All lab reports
View full certificate from 10 December 2025 (PDF, opens in a new tab)

Latest result

  • 122% Of expected amount 12.2 mg measured, 10 mg expected
Sample tested
Finished product
Analysis date
10 December 2025
Laboratory
MZ Biolabs
Lab lot
2025-11-21
Identity
Molecular weight confirmed
Method
HPLC-UV-MS

SR9009 (Stenabolic) and the REV-ERB clock receptors

REV-ERB in brief

REV-ERBα and REV-ERBβ are nuclear receptors that repress the transcription of core clock genes, including BMAL1. They link the daily timing system of the cell with the regulation of metabolic genes, and their natural ligand is haem. The name comes from the position of the first REV-ERB gene on the reverse strand of the ERBA gene. SR9009 is a synthetic small molecule made to activate them. It has nothing to do with the androgen receptor, so calling it a SARM is a mistake.

How SR9009 has been used

The compound was described in 2012 by a group at Scripps Research, together with a sister compound, SR9011. The original experiments were in mice and looked at circadian behaviour and the expression of clock and metabolic genes in liver, muscle and fat tissue. It has since been used widely in cell culture as a probe for REV-ERB. Later work reported that some of its effects persist in cells lacking both receptors, so careful studies now include controls for off-target activity. SR9009 has not been through clinical trials.

Tablets supplied

A Dynamic Performance pouch of 60 tablets, each containing 10mg of Stenabolic (SR9009). Keep the pouch closed and store it somewhere cool and dry, out of the light. The tablets are sold as a research reference material and are not a medicine or a food supplement.

Other spellings

  • SR-9009

Products are supplied for research purposes only and are for sale to persons aged 18 and over.